Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Braskem (BAK) Financials

Braskem logo
$4.83 -0.02 (-0.39%)
Closing price 05/20/2026 03:59 PM Eastern
Extended Trading
$4.78 -0.05 (-1.06%)
As of 05/20/2026 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Braskem

Annual Income Statements for Braskem

This table shows Braskem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 758 -534 1,197 750 -682 -1,413 2,500 -162 -2,016 -3,898 -2,001
Consolidated Net Income / (Loss)		 697 -224 1,182 739 -657 -1,351 2,504 -155 -1,008 -1,949 -2,001
Net Income / (Loss) Continuing Operations		 696 -445 1,178 739 -657 -1,351 2,504 -162 -1,952 -3,779 -1,996
Total Pre-Tax Income 		1,115 -213 1,589 929 -1,145 -1,864 3,222 2.27 -2,220 -4,698 -515
Total Operating Income		 1,740 553 1,545 1,072 -1,528 -1,090 3,518 -246 -3,020 -3,285 141
Total Gross Profit		 2,572 3,897 3,950 2,944 1,603 2,159 5,750 2,149 -2,037 -2,462 284
Total Revenue		 11,840 12,653 14,873 14,947 13,019 11,271 18,947 17,301 12,448 9,579 13,330
Operating Revenue		 11,840 12,653 14,873 14,947 13,019 11,271 18,947 17,301 12,448 9,579 13,330
Total Cost of Revenue		 9,269 10,023 12,407 12,921 13,488 11,587 14,555 16,554 14,485 12,041 12,628
Operating Cost of Revenue		 9,269 10,023 12,407 12,921 13,488 11,587 14,555 16,554 14,485 12,041 12,628
Total Operating Expenses		 560 2,077 920 954 1,059 774 874 992 983 824 561
Selling, General & Admin Expense		 277 827 870 897 997 726 821 922 904 749 477
Research & Development Expense		 43 50 51 57 62 48 53 71 79 75 84
Total Other Income / (Expense), net		 -625 -765 44 -143 383 -774 -296 248 800 -1,413 -655
Other Income / (Expense), net		 26 -987 -138 -295 171 -890 -579 -12 454 -1,691 -655
Income Tax Expense		 419 - 411 190 -488 -514 717 164 -268 -919 1,482
Weighted Average Basic Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 0.00 0.00 797.21M
Weighted Average Diluted Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 0.00 0.00 797.21M
Weighted Average Basic & Diluted Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 0.00 0.00 797.21M

Quarterly Income Statements for Braskem

No quarterly income statements for Braskem are available.

Annual Cash Flow Statements for Braskem

This table details how cash moves in and out of Braskem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -1,017 -1,149 -2,823 117 -5,483 3,209 -1,117 711 -834 -67 -398
Net Cash From Operating Activities		 -52 260 -1,847 1,176 -4,652 3,734 564 1,883 86 533 166
Net Cash From Continuing Operating Activities		 -52 260 -1,847 1,176 -4,652 3,734 564 1,883 86 533 166
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense		 537 825 884 771 904 779 749 895 1,073 800 853
Non-Cash Adjustments To Reconcile Net Income		 -802 507 -2,312 48 -5,782 3,151 -751 952 -1,404 -309 -442
Changes in Operating Assets and Liabilities, net		 213 -1,072 -419 358 226 -196 566 35 417 41 -244
Net Cash From Investing Activities		 -843 -795 -674 -673 -664 -525 -606 -917 -919 -599 -565
Net Cash From Continuing Investing Activities		 -843 -795 -674 -673 -664 -525 -606 -917 -919 -599 -565
Purchase of Property, Plant & Equipment		 -843 -795 -686 -697 -667 -531 -614 -917 -934 -608 -565
Sale of Property, Plant & Equipment		 0.32 0.17 12 25 3.13 6.38 7.18 0.38 15 9.06 0.00
Net Cash From Financing Activities		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97 0.00
Net Cash From Continuing Financing Activities		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97 0.00
Payment of Dividends		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97 0.00
Cash Interest Paid		 -473 562 650 494 557 527 517 550 732 689 808

Quarterly Cash Flow Statements for Braskem

No quarterly cash flow statements for Braskem are available.

Annual Balance Sheets for Braskem

This table presents Braskem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 15,930 15,921 15,155 16,952 16,573 16,604 16,657 18,907 16,425 14,950
Total Current Assets		 4,886 5,259 5,421 5,820 6,582 7,048 6,519 7,716 5,989 5,559
Cash & Equivalents		 2,060 1,140 1,430 1,693 2,669 1,557 2,358 2,924 2,423 1,917
Short-Term Investments		 369 696 615 421 705 633 464 1,050 301 311
Accounts Receivable		 558 1,078 909 722 1,001 1,459 749 771 703 845
Inventories, net		 1,721 2,005 2,187 1,897 1,614 2,930 2,654 2,583 2,213 1,903
Current Deferred & Refundable Income Taxes		 254 - 218 418 230 256 219 301 222 494
Plant, Property, & Equipment, net		 9,018 8,986 8,185 8,041 6,917 6,677 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 1,300 1,352 1,534 3,092 3,022 2,802 2,906 3,216 3,853 2,488
Noncurrent Note & Lease Receivables		 65 45 53 70 48 68 36 100 88 103
Intangible Assets		 863 823 706 687 545 516 572 641 548 559
Noncurrent Deferred & Refundable Income Taxes		 335 352 690 1,284 1,849 1,706 1,509 1,610 2,529 935
Other Noncurrent Operating Assets		 - 128 64 1,033 569 499 761 831 688 891
Total Liabilities & Shareholders' Equity		 15,930 15,921 15,155 16,952 16,573 16,604 16,657 18,907 16,425 14,950
Total Liabilities		 10,203 9,684 9,596 13,482 12,675 13,221 13,611 16,486 15,908 14,851
Total Current Liabilities		 7,052 5,605 5,867 4,035 5,465 4,519 4,575 5,048 4,572 7,343
Short-Term Debt		 798 366 197 2,503 1,111 2,444 2,248 2,584 2,677 1,839
Accounts Payable		 2,158 1,611 2,310 2,500 2,005 2,461 2,616 3,179 3,067 2,758
Other Taxes Payable		 173 461 111 80 183 182 93 80 268 235
Other Current Liabilities		 8.93 56 70 360 356 251 408 478 296 355
Total Noncurrent Liabilities		 8,319 8,664 7,831 11,935 11,852 10,972 10,926 13,184 12,545 10,619
Long-Term Debt		 6,374 6,696 6,268 7,069 7,888 6,084 6,511 8,316 8,240 7,952
Capital Lease Obligations		 - - 23 498 445 445 606 609 535 593
Asset Retirement Reserve & Litigation Obligation		 - - - - - 207 222 226 137 168
Noncurrent Deferred & Payable Income Tax Liabilities		 7.41 320 138 109 293 599 347 390 293 280
Noncurrent Employee Benefit Liabilities		 - 59 53 97 91 87 93 117 89 92
Other Noncurrent Operating Liabilities		 407 116 85 109 145 251 311 338 306 578
Total Equity & Noncontrolling Interests		 529 1,652 1,457 982 -744 1,113 1,156 676 -692 -3,013
Total Preferred & Common Equity		 842 1,902 1,683 1,216 -424 1,411 1,385 823 -773 -2,948
Total Common Equity		 842 1,902 1,683 1,216 -430 780 1,132 923 -694 -2,859
Common Stock		 2,472 2,281 1,947 1,880 1,454 1,355 1,522 1,658 1,301 1,469
Retained Earnings		 - -66 -66 0.00 -872 - 0.00 -564 -2,269 -4,364
Accumulated Other Comprehensive Income / (Loss)		 -1,943 -1,560 -1,449 -1,184 -1,003 -569 -393 -176 272 35
Other Equity Adjustments		 328 1,262 1,264 532 0.00 0.62 3.22 5.56 2.10 2.01
Noncontrolling Interest		 -313 -250 -226 -234 -320 -298 -230 -147 82 -65

Quarterly Balance Sheets for Braskem

No quarterly balance sheets for Braskem are available.

Annual Metrics And Ratios for Braskem

This table displays calculated financial ratios and metrics derived from Braskem's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 797,207,834.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 797,207,834.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -2.51
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 6.86% 17.55% 0.50% -12.90% -13.43% 68.10% -8.69% -22.59% -6.53% 39.15%
EBITDA Growth		 0.00% -83.03% 486.34% -32.45% -129.28% -164.91% 407.16% -82.71% -186.32% -329.18% 108.11%
EBIT Growth		 0.00% -124.57% 424.30% -44.77% -274.61% -45.90% 248.40% -108.77% -530.06% -94.84% 89.66%
NOPAT Growth		 0.00% -64.35% 195.95% -25.54% -225.41% 28.67% 458.40% 540.59% -108.30% 29.93% 104.28%
Net Income Growth		 0.00% -132.15% 627.45% -37.48% -188.88% -105.58% 285.43% -106.20% -548.88% -93.38% -2.69%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -295.41% 241.58% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% 598.37% -811.13% 163.66% -495.58% 180.27% -84.88% 233.55% -95.45% 521.47% -68.78%
Free Cash Flow Firm Growth		 0.00% 0.00% 101.67% 882.04% -209.66% 123.44% 522.93% 913.44% -104.22% -54.78% 146.08%
Invested Capital Growth		 0.00% 0.00% 10.03% -6.42% 6.20% -10.78% 2.65% -77.15% -17.49% 33.41% -50.21%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 21.72% 30.80% 26.56% 19.70% 12.32% 19.15% 30.35% 12.42% 4.65% 7.75% 2.13%
EBITDA Margin		 19.45% 3.09% 15.41% 10.36% -3.48% -10.65% 19.46% 3.69% -4.11% -18.87% 2.54%
Operating Margin		 14.70% 4.37% 10.39% 7.17% -11.74% -9.67% 18.57% -1.42% -15.50% -11.62% 1.06%
EBIT Margin		 14.92% -3.43% 9.46% 5.20% -10.42% -17.57% 15.51% -1.49% -12.12% -25.27% -3.86%
Profit (Net Income) Margin		 5.89% -1.77% 7.95% 4.95% -5.05% -11.98% 13.22% -0.90% -7.53% -15.57% -15.01%
Tax Burden Percent		 62.53% 105.45% 74.38% 79.57% 57.36% 72.44% 77.74% -6,841.67% 78.88% 67.96% 388.96%
Interest Burden Percent		 63.13% 48.98% 112.95% 119.53% 84.40% 94.16% 109.65% -0.88% 78.70% 90.66% 100.00%
Effective Tax Rate		 37.61% 0.00% 25.88% 20.43% 0.00% 0.00% 22.26% 7,233.34% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 7.86% 11.08% 8.13% -10.23% -7.49% 28.09% 289.12% -70.68% -46.94% 5.19%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -5.26% 11.47% 6.86% -5.76% -13.32% 25.68% -69.75% -31.62% -89.66% -50.79%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -92.62% 97.32% 39.41% -43.65% -1,131.61% 1,331.43% -302.82% -39.39% 24,415.22% 102.85%
Return on Equity (ROE)		 0.00% -84.76% 108.40% 47.54% -53.88% -1,139.10% 1,359.51% -13.69% -110.07% 24,368.28% 108.04%
Cash Return on Invested Capital (CROIC)		 0.00% -192.14% 1.52% 14.76% -16.24% 3.91% 25.47% 414.74% -51.51% -75.56% 72.22%
Operating Return on Assets (OROA)		 0.00% -2.72% 8.84% 5.00% -8.45% -11.81% 17.71% -1.55% -9.13% -17.90% -3.28%
Return on Assets (ROA)		 0.00% -1.41% 7.42% 4.76% -4.09% -8.06% 15.10% -0.93% -5.67% -11.03% -12.76%
Return on Common Equity (ROCE)		 0.00% -134.89% 136.37% 54.81% -64.04% -3,773.16% 1,292.24% -11.55% -123.53% -348,778.58% 103.63%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -26.63% 62.15% 43.92% -54.05% 318.54% 177.50% -11.21% -122.50% 252.03% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,086 387 1,145 853 -1,070 -763 2,734 17,516 -1,453 -1,018 99
NOPAT Margin		 9.17% 3.06% 7.70% 5.71% -8.22% -6.77% 14.43% 101.24% -10.85% -8.14% 0.74%
Net Nonoperating Expense Percent (NNEP)		 0.00% 13.12% -0.40% 1.27% -4.47% 5.84% 2.41% 358.87% -39.06% 42.73% 55.98%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 166.50% -11.93% -9.45% 1.34%
Cost of Revenue to Revenue		 78.28% 79.21% 83.42% 86.45% 103.60% 102.80% 76.82% 95.68% 108.16% 105.04% 94.73%
SG&A Expenses to Revenue		 2.34% 6.53% 5.85% 6.00% 7.66% 6.44% 4.33% 5.33% 6.75% 5.98% 3.58%
R&D to Revenue		 0.36% 0.39% 0.34% 0.38% 0.47% 0.43% 0.28% 0.41% 0.59% 0.60% 0.63%
Operating Expenses to Revenue		 4.73% 16.42% 6.19% 6.38% 8.13% 6.87% 4.62% 5.74% 7.34% 6.58% 4.21%
Earnings before Interest and Taxes (EBIT)		 1,766 -434 1,407 777 -1,357 -1,980 2,938 -258 -1,623 -3,163 -515
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,303 391 2,292 1,548 -453 -1,201 3,688 638 -550 -2,363 339
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 2.41 0.00 10.77 3.24 3.81 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 5.54 0.00 31.82 6.54 12.43 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.22 0.16 0.44 0.21 0.26 0.12 0.09
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 3.36 0.00 0.00 0.00 0.00
Dividend Yield		 4.52% 9.61% 3.82% 9.44% 19.09% 0.00% 12.85% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 29.74% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.99 0.78 1.51 4.41 5.85 4.15 7.34
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.82 0.67 0.79 0.58 0.81 0.82 0.70
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 4.03 15.60 0.00 0.00 27.36
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 5.06 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 5.44 0.57 0.00 0.00 94.05
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 2.01 26.36 5.28 126.79 19.32 55.71
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 18.90 6.00 0.40 0.00 0.00 6.76
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 13.56 4.27 4.45 10.26 -12.69 8.06 8.10 17.03 -16.58 -3.45
Long-Term Debt to Equity		 0.00 12.05 4.05 4.32 7.71 -11.19 5.87 6.16 13.21 -12.71 -2.84
Financial Leverage		 0.00 17.62 8.48 5.75 7.57 84.93 51.85 4.34 1.25 -272.29 -2.02
Leverage Ratio		 0.00 30.12 14.60 9.99 13.17 141.38 90.05 14.66 19.42 -2,208.95 -8.47
Compound Leverage Factor		 0.00 14.75 16.49 11.95 11.11 133.12 98.74 -0.13 15.28 -2,002.62 -8.47
Debt to Total Capital		 0.00% 93.13% 81.04% 81.66% 91.12% 108.56% 88.97% 89.02% 94.45% 106.42% 140.88%
Short-Term Debt to Total Capital		 0.00% 10.36% 4.20% 2.48% 22.65% 12.77% 24.24% 21.37% 21.21% 24.84% 24.95%
Long-Term Debt to Total Capital		 0.00% 82.78% 76.84% 79.18% 68.47% 95.78% 64.73% 67.65% 73.24% 81.58% 115.93%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -4.06% -2.87% -2.84% -2.12% -3.68% -2.96% -2.18% -1.21% 0.76% -0.88%
Common Equity to Total Capital		 0.00% 10.93% 21.83% 21.18% 11.00% -4.94% 7.74% 10.76% 7.58% -6.44% -38.79%
Debt to EBITDA		 0.00 18.35 3.08 4.19 -22.22 -7.87 2.43 14.68 -20.91 -4.85 30.66
Net Debt to EBITDA		 0.00 12.04 2.28 2.86 -17.52 -5.05 1.84 10.21 -13.63 -3.67 24.08
Long-Term Debt to EBITDA		 0.00 16.31 2.92 4.06 -16.70 -6.94 1.77 11.16 -16.21 -3.72 25.23
Debt to NOPAT		 0.00 18.53 6.16 7.61 -9.42 -12.38 3.28 0.53 -7.92 -11.26 105.38
Net Debt to NOPAT		 0.00 12.16 4.56 5.19 -7.42 -7.94 2.48 0.37 -5.16 -8.52 82.77
Long-Term Debt to NOPAT		 0.00 16.47 5.85 7.38 -7.08 -10.92 2.39 0.41 -6.14 -8.63 86.72
Altman Z-Score		 0.00 0.00 0.00 0.00 0.76 0.38 2.29 1.29 0.68 0.09 0.27
Noncontrolling Interest Sharing Ratio		 0.00% -59.15% -25.80% -15.30% -18.86% -231.24% 4.95% 15.69% -12.24% 1,531.28% 4.08%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 0.69 0.94 0.92 1.44 1.20 1.56 1.42 1.53 1.31 0.76
Quick Ratio		 0.00 0.42 0.52 0.50 0.70 0.80 0.81 0.78 0.94 0.75 0.42
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -9,462 158 1,549 -1,698 398 2,479 25,126 -1,059 -1,639 1,371
Operating Cash Flow to CapEx		 -6.18% 32.68% -273.92% 174.76% -700.25% 711.37% 93.08% 205.39% 9.33% 88.93% 29.46%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -1.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.79 0.93 0.96 0.81 0.67 1.14 1.04 0.75 0.71 0.85
Accounts Receivable Turnover		 0.00 22.68 18.19 15.05 15.97 13.09 15.41 15.67 17.62 16.98 17.22
Inventory Turnover		 0.00 5.82 6.66 6.16 6.60 6.60 6.41 5.93 5.53 5.48 6.14
Fixed Asset Turnover		 0.00 1.40 1.65 1.74 1.60 1.51 2.79 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 4.64 6.58 6.59 5.61 5.14 6.52 6.52 5.00 4.21 4.34
Days Sales Outstanding (DSO)		 0.00 16.10 20.07 24.26 22.86 27.89 23.69 23.29 20.71 21.49 21.19
Days Inventory Outstanding (DIO)		 0.00 62.66 54.80 59.21 55.26 55.31 56.98 61.56 65.98 66.57 59.49
Days Payable Outstanding (DPO)		 0.00 78.60 55.44 55.38 65.08 70.95 56.00 55.98 73.01 86.69 84.20
Cash Conversion Cycle (CCC)		 0.00 0.16 19.43 28.08 13.04 12.24 24.67 28.88 13.68 1.37 -3.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 9,849 10,836 10,141 10,769 9,608 9,863 2,253 1,859 2,480 1,262
Invested Capital Turnover		 0.00 2.57 1.44 1.43 1.25 1.11 1.95 2.86 6.51 5.77 7.02
Increase / (Decrease) in Invested Capital		 0.00 9,849 988 -696 629 -1,161 255 -7,610 -394 621 -1,273
Enterprise Value (EV)		 0.00 0.00 0.00 0.00 10,632 7,522 14,879 9,947 10,870 10,293 9,267
Market Capitalization		 0.00 0.00 0.00 0.00 2,928 1,783 8,407 3,663 3,516 1,539 1,176
Book Value per Share		 $0.00 $0.00 $2.39 $3.73 $2.69 ($0.95) $0.98 $1.42 $1.16 ($0.87) ($3.59)
Tangible Book Value per Share		 $0.00 $0.00 $1.35 $2.16 $1.17 ($2.16) $0.33 $0.70 $0.35 ($1.56) ($4.29)
Total Capital		 0.00 7,701 8,714 7,946 11,051 8,700 10,086 10,520 12,185 10,776 7,371
Total Debt		 0.00 7,172 7,062 6,489 10,070 9,445 8,973 9,365 11,509 11,468 10,384
Total Long-Term Debt		 0.00 6,374 6,696 6,291 7,567 8,333 6,529 7,116 8,925 8,791 8,545
Net Debt		 0.00 4,706 5,222 4,425 7,938 6,060 6,770 6,514 7,501 8,673 8,156
Capital Expenditures (CapEx)		 843 795 674 673 664 525 606 917 919 599 565
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -3,797 -1,816 -2,294 2,174 -1,145 2,784 1,369 1,279 1,370 -2,173
Debt-free Net Working Capital (DFNWC)		 0.00 -1,368 20 -249 4,288 2,229 4,974 4,191 5,253 4,094 55
Net Working Capital (NWC)		 0.00 -2,166 -346 -446 1,785 1,117 2,529 1,943 2,668 1,417 -1,784
Net Nonoperating Expense (NNE)		 388 611 -37 114 -413 588 230 17,672 -446 930 2,100
Net Nonoperating Obligations (NNO)		 0.00 9,320 9,184 8,683 9,788 10,353 8,751 1,098 1,183 3,172 4,275
Total Depreciation and Amortization (D&A)		 537 825 884 771 904 779 749 895 1,073 800 853
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -30.01% -12.21% -15.35% 16.70% -10.16% 14.69% 7.91% 9.55% 10.95% -16.30%
Debt-free Net Working Capital to Revenue		 0.00% -10.82% 0.14% -1.67% 32.93% 19.77% 26.25% 24.23% 39.22% 32.71% 0.41%
Net Working Capital to Revenue		 0.00% -17.12% -2.33% -2.99% 13.71% 9.91% 13.35% 11.23% 19.92% 11.32% -13.38%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $18.15 ($1.26) ($17.24) ($6.89) $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M 797.21M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $18.10 ($1.26) ($17.24) ($6.89) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M 797.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M 797.21M
Normalized Net Operating Profit after Tax (NOPAT)		 1,086 387 1,145 853 -1,070 -763 2,734 -172 -1,453 -1,018 99
Normalized NOPAT Margin		 9.17% 3.06% 7.70% 5.71% -8.22% -6.77% 14.43% -0.99% -10.85% -8.14% 0.74%
Pre Tax Income Margin		 9.42% -1.68% 10.69% 6.22% -8.80% -16.54% 17.00% 0.01% -9.54% -22.91% -3.86%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 2.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 1.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 1.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 17.47% -274.00% 25.51% 52.29% -25.33% -0.03% 42.92% -164.43% -0.14% -0.05% 0.00%
Augmented Payout Ratio		 17.47% -274.00% 25.51% 52.29% -25.33% -0.03% 42.92% -164.43% -0.14% -0.05% 0.00%

Quarterly Metrics And Ratios for Braskem

No quarterly metrics and ratios for Braskem are available.


Financials Breakdown Chart

Braskem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Braskem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Braskem's net income appears to be on an upward trend, with a most recent value of -$2.00 billion in 2025, falling from $697.14 million in 2015. The previous period was -$1.95 billion in 2024. Check out Braskem's forecast to explore projected trends and price targets.

Braskem's total operating income in 2025 was $140.77 million, based on the following breakdown:
  • Total Gross Profit: $284.10 million
  • Total Operating Expenses: $561.44 million

Over the last 10 years, Braskem's total revenue changed from $11.84 billion in 2015 to $13.33 billion in 2025, a change of 12.6%.

Braskem's total liabilities were at $14.85 billion at the end of 2025, a 6.6% decrease from 2024, and a 45.5% increase since 2016.

In the past 9 years, Braskem's cash and equivalents has ranged from $1.14 billion in 2017 to $2.92 billion in 2023, and is currently $1.92 billion as of their latest financial filing in 2025.

Over the last 10 years, Braskem's book value per share changed from 0.00 in 2015 to -3.59 in 2025, a change of -358.6%.


Related Companies

Financial statements for NYSE:BAK last updated on 4/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel